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Abstract
Objectives—Evidence-based guidelines have long recommended that HIV care providers deliver 
HIV transmission risk-reduction (RR) services, but recent data are needed to assess their adoption.
Methods—We surveyed a probability sample of 1,234 U.S. HIV care providers on delivery of 9 
sexual behavior- and 7 substance use-related HIV transmission RR services, and created an 
indicator of “adequate” delivery of services in each area, defined as performing approximately 
70% or more of applicable services.
Results—Providers were most likely to encourage patients to disclose HIV status to all partners 
since HIV diagnosis (81%) and least likely to ask about disclosure to new sex and drug injection 
partners at follow-up visits (both 41%). Adequate delivery of sexual behavior- and substance use-
related RR services was low (37% and 43%, respectively).
Conclusion—The majority of U.S. HIV care providers may need additional support to improve 
delivery of comprehensive HIV transmission RR services.
Introduction
Improvements in treatment and a relatively stable number of new infections have resulted in 
a growing population of persons living with HIV in the United States and an increasing 
public health need to support HIV-infected persons in reducing behaviors that may transmit 
HIV to others. Although biomedical approaches to prevention have grown in importance, 
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behavioral prevention services are still recognized as necessary and effective components of 
a combination approach to HIV prevention. Evidence-based federal guidelines for HIV 
prevention, including the newly published Recommendations for HIV Prevention with 
Adults and Adolescents with HIV in the United States, have long recommended that HIV 
care providers deliver an array of behavioral prevention services to HIV-infected patients to 
prevent transmission of HIV1, 2, and delivery of these services is also recommended as an 
essential element of quality HIV clinical care3, 4. Recommended services include risk 
screening for sexual risk behaviors, substance use, symptoms of STDs, and current sex and 
drug injection partners, in addition to provision of risk-reduction (RR) intervention services, 
which include provider-delivered RR counseling and provision of or referral to intensive RR 
interventions for those who continue risky behaviors. Moreover, providers are recommended 
to encourage patients to disclose their HIV status to all sex and drug injection partners since 
the time of diagnosis and on an ongoing basis, in addition to assisting the patient with 
partner notification through referral to partner services.
Despite these longstanding recommendations and the efficacy of RR services2, 5, 6, the 
available evidence suggests that delivery of prevention services by health care providers is 
suboptimal. Among a national probability sample of HIV care providers participating in the 
Medical Monitoring Project (MMP) provider survey in 2009, 66% reported always 
discussing HIV transmission RR and 35% reported always discussing partner counseling 
services with patients who were new to HIV medical care7. Because studies find that 
providers are more likely to provide RR services at initial as opposed to follow-up visits8, 9, 
delivery of these services to all HIV-infected patients was likely lower. An analysis of MMP 
patient interview data collected in 2009-2010 found that only 44% of U.S. HIV patients 
reported having a discussion with a health care provider about HIV/STD prevention10. 
Observational studies of patient encounters have also documented low levels of RR 
screening and counseling, even when indicators of risk behavior were present11, 12.
Recent surveys of health care providers have identified provider characteristics (profession, 
age, race/ethnicity, attitudes towards prevention counseling) and practice characteristics 
(time allotted to patient visits, number of HIV-infected patients) that are associated with 
nonadherence to recommendations regarding delivery of prevention services7, 9, 13. In most 
surveys, RR services are either measured by a global question (e.g., how often do you 
discuss transmission risk-reduction)7, 13 or a limited number of questions9, 14. These 
shortcomings in measurement limit the ability of these studies to identify which RR services 
are least often provided—information needed to inform efforts to improve delivery of RR 
services. Also, most provider surveys have not examined delivery of HIV transmission RR 
services related to alcohol and drug use or disclosure of HIV status to the partners of persons 
who inject drugs (PWID), which are key parts of a comprehensive approach to RR. 
Although one study found that 77% of providers in 7 hospital-based HIV care centers 
reported asking most or all patients seen in the past month about alcohol use15, to our 
knowledge an assessment of provision of more comprehensive substance use-related HIV 
transmission RR services by clinicians in a wide range of care settings has not been 
published.
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The present study extends the earlier work discussed above7-9, 11-14 by presenting analyses 
of more recent data from providers in a variety of clinical settings across the United States 
and by examining delivery of a broader range of HIV RR services, including those related to 
alcohol and drug use, which may help to identify specific areas needing improvement. 
Further, to guide efforts to increase delivery of RR services, we identify provider and 
practice characteristics independently associated with provision of adequate HIV risk-
reduction services in two areas: sexual behavior and substance use.
Methods
We analyzed data collected from the 2013 MMP Provider Survey, which was conducted in 
the geographic areas and HIV care facilities sampled for MMP in 201116, 17. The Provider 
Survey used a complex two-stage sample design, first by selecting 16 states and 1 territory 
using probability proportionate to size (PPS) sampling, with size based on estimates of the 
number of AIDS cases. All sampled geographic areas agreed to participate in MMP, 
including: California, Delaware, Florida, Georgia, Illinois, Indiana, Michigan, Mississippi, 
New Jersey, New York, North Carolina, Oregon, Pennsylvania, Puerto Rico, Texas, Virginia, 
and Washington. Second, 622 facilities within these areas were sampled using PPS based on 
the number of persons receiving care for HIV infection, and 505 of these facilities 
participated in the Provider Survey (81% crude participation rate). Participating facilities 
provided a list of 2,208 providers, all of whom were invited to participate in the MMP 
provider survey. Providers were eligible to participate in the survey if they were physicians, 
physician assistants or nurse practitioners who had completed their training and provided 
HIV care (defined as ordering CD4+ T-lymphocyte cell (CD4) count or HIV viral load tests 
and/or prescribing antiretroviral medications) between January and April 2012. Providers 
were recruited with a modified version of Dillman's Tailored Design Method18, which 
included mailing individualized recruitment packets to all of the providers in participating 
facilities, with follow-up letters and emails sent at set intervals between June 2013 and 
January 2014. The recruitment packets included a letter from the Centers for Disease 
Control and Prevention (CDC) explaining the purpose of the survey, instructions for 
completing the self-administered survey via paper or a web-based response system, and a 
$20 cash incentive. The recruitment materials explained the voluntary nature of the survey; 
written informed consent was not obtained. In all, 2,023 of 2,208 providers were determined 
to be eligible, and 1,234 of the eligible providers returned surveys (American Association 
for Public Opinion Research RR3 = 64%19) from 391 HIV care facilities. The data were 
then weighted based on probability of selection, and response propensity adjustments of the 
design weights were performed to correct for possible nonresponse bias. Nonresponse 
adjustments were made to the sampling weights based on provider and facility factors 
associated with nonresponse: provider profession, number of HIV care providers practicing 
at the facility, facility university affiliation, whether the facility was a private practice or a 
community health center, and whether the facility had a computerized system for 
medications or lab results.
The 2013 MMP provider survey instrument consisted of 61 questions and required 
approximately thirty minutes to complete. For this analysis, we focused on provider-
delivered services intended to reduce HIV transmission risk in two areas: sexual behaviors 
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and alcohol and drug use (“substance use”). Each provider was asked whether they provided 
each of 9 sexual behavior-related and 7 substance use-related HIV transmission RR services 
to most or all of their patients (Table 2). We constructed two composite variables indicating 
“adequate” sexual behavior-related and substance use-related HIV transmission RR service 
delivery, using a standard of approximately 70% of services delivered20. Adequate sexual 
behavior-related RR was defined as providing at least 7 of 9 sexual RR services for most or 
all of the provider's patients (or 6 of 8 in the case of providers who did not see patients at 
initial visits). Adequate substance use-related RR was defined as providing at least 5 of 7 
substance use RR services for most or all of the provider's patients (or 4 of 6 in the case of 
providers who did not see patients at initial visits) among providers seeing persons who 
inject drugs (PWID). Independent variables were chosen based on prior studies of provider-
delivered HIV transmission RR7, 9, 13, and included age, gender, sexual orientation, race/
ethnicity, provider type, years caring for HIV patients, primary care provision, language, 
number of patients, satisfaction with support services, having sufficient time to see patients, 
and patient characteristics. Also examined was HIV specialist designation, which was based 
on meeting criteria established by the HIV Medicine Association21 or the American 
Academy of HIV Medicine22, and utilization of an integrated team, which was defined as 
multiple clinicians working together to augment the provider visit by providing pre-visit, 
post-visit, or between-visit contact with HIV-infected patients.
We computed weighted estimates of percentages and associated 95% confidence intervals 
(CIs) to describe the target population of providers. Rao-Scott chi-square tests were used to 
test bivariate associations between selected independent variables and the two adequate RR 
services variables. All independent variables having associations of p<0.05 were included in 
logistic regression models predicting the two dependent variables. Based on examination of 
frequencies, number of HIV patients was also included in the models to assess whether there 
was a significant curvilinear association between this variable and the two dependent 
variables. Prevalence ratios for the independent variables were computed using methods 
described by Bieler et al23. All estimates incorporated the survey weights, and variance 
estimates were computed using Taylor Series Linearization to reflect the complex features of 
the MMP provider sample. We used SAS/STAT (Version 9.3, SAS Institute Inc., Cary, NC, 
USA) and SUDAAN (Version 11, RTI International, Research Triangle Park, NC, USA) 
procedures for the analysis of complex sample survey data, and considered estimates with a 
coefficient of variation greater than 0.3 unreliable.
Results
We estimate that the majority of HIV care providers in the United States in 2013 were over 
age 49 (58%), male (57%), heterosexual (85%), non-Hispanic white (63%), and physicians 
(medical doctors or osteopaths) (79%) (Table 1). Over half were HIV specialists (58%) and 
most provided primary care to their HIV-infected patients (83%). About half (50%) were 
satisfied with the level of support services available in their practice and 54% utilized an 
integrated team in their practice.
The sexual behavior-related HIV transmission RR services most frequently provided to most 
or all patients were encouraging patient disclosure of HIV status to all sex partners (81%), 
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asking patients newly diagnosed with an STD about disclosure of HIV status to sex partners 
(69%), and asking about HIV disclosure to all sex partners at a patient's initial visit (62%) 
(Table 2). Asking about HIV disclosure to new sex partners at follow-up visits (41%), 
offering condoms to sexually active patients (42%), and referring patients to partner services 
for assistance with notifying sex partners who had not been informed of their exposure to 
HIV (53%) were the services least likely to be provided to most or all patients. We estimate 
that 38% of providers offered condoms to few or none of their sexually active patients and 
16% referred few or no patients to the health department for assistance with notifying sex 
partners who had not been informed of their HIV exposure. Screening for sexual risk 
behaviors and for symptoms of STDs in sexually active patients was only done for most or 
all patients by a little more than half of providers, and between 20-24% of providers did this 
for half or fewer of their patients. Examination of our composite variable indicates that 
adequate delivery of recommended sexual behavior-related RR services to most or all 
patients was low (37%).
The substance use-related HIV transmission RR services most frequently provided to most 
or all patients were assessing substance use every 6 months (64%) and encouraging patient 
disclosure of HIV status to all drug-injecting partners (61%) (Table 3). Asking about HIV 
disclosure to new drug-injecting partners at follow-up visits (41%), informing PWID about 
sterile syringe sources (43%), and referral to partner services for drug-injecting partners that 
have not been informed of their possible exposure to HIV (45%) were the least likely to be 
provided to most or all patients. We estimate that 24% of providers discussed sources of 
sterile syringes with few or no patients who shared drug injection equipment and 20% 
referred few or no patients to the health department to discuss drug-injecting partners that 
had not been informed of their HIV exposure. Overall, adequate delivery of recommended 
substance use-related RR services to most or all patients was also suboptimal (43%).
Factors independently associated with providing adequate sexual behavior-related RR 
services were being a nurse practitioner (adjusted prevalence ratio [aPR] 1.59), having 6-10 
years of HIV care experience compared to over 20 (aPR:1.70), providing primary care (aPR:
1.56), and having more than 50% of patients who were men who have sex with men (MSM) 
(aPR:0.79) (Table 3). Factors independently associated with providing adequate substance 
use-related HIV RR services were being a nurse practitioner (aPR:1.59) and being an HIV 
specialist (aPR:1.27), and having more than 50% of patients who were PWID (aPR:1.56) 
(Table 4).
Discussion
The majority of U.S. HIV care providers may need additional support to improve delivery of 
comprehensive HIV transmission RR services to their patients. Services provided most 
consistently were those related to disclosure of HIV status to all sex and drug injection 
partners since HIV diagnosis and to sex partners at the time of an STD diagnosis, as well as 
assessment of alcohol and drug use every six months. Providers were least likely to ask 
patients at follow-up visits if any new sex or drug-injecting partners were notified of 
possible HIV exposure, to inform PWID about sources of sterile syringes, and to offer 
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condoms to sexually active patients. The proportion of providers who refer patients to 
partner services for their sex and drug-injecting partners was also low.
Encouraging disclosure of HIV status to sex and drug-injecting partners at initial evaluations 
was more common than doing so at follow-up visits, as has been found by others9. Follow-
up visits are generally allotted less time than initial visits, but we did not find an association 
between delivering adequate RR services and satisfaction with time spent with either new or 
established patients, as has sometimes been found by others13. Beyond the shorter time 
allotted to follow-up visits, providers may feel that discussing risk behaviors and HIV 
disclosure is not needed with patients who have not reported risk behaviors in prior 
encounters. However, because behaviors are dynamic and people with HIV are living longer, 
routine delivery of prevention services at follow-up visits is essential.
Delivery of services that require structural supports such as condom provision and 
information about sources of sterile syringes was also low. Delivery of these services may 
not entirely be at the discretion of the provider, as condoms and sterile syringes may not be 
available in all settings. For example, having condoms freely available to patients requires 
some coordination between the care facility and those who can provide the condoms, such as 
condom manufacturers or community-based prevention organizations. State and federal laws 
may affect the availability of syringe exchange and prescription options. However, use of 
condoms and sterile syringes are effective behavioral interventions that reduce the risk of 
HIV transmission, and HIV care providers can be instrumental in promoting their use. 
Although free condoms may also be available from other sources (such as community-based 
organizations or social venues), health care settings are an important point of access. In 
2011, approximately 64% of U.S. HIV-infected patients who received free condoms 
obtained them from a general health clinic24.
Consistent with prior work, referral to partner services for both sex and drug-injecting 
partners was also less frequently delivered7. Because health department-delivered partner 
services can be a cost-effective means of identifying new HIV infections and disrupting HIV 
transmission chains2, and early identification of HIV infection and subsequent treatment 
with ART improves likelihood of treatment success and decreases the risk of onward HIV 
transmission25, enhanced efforts to increase provider referral of patients to partner services 
are warranted. The newly published Recommendations for HIV Prevention with Adults and 
Adolescents with HIV in the United States provides recommendations for clinical providers 
on strategies to establish infrastructure for HIV partner services2. Communicating with 
providers about partner services from a patient's perspective may also help; evidence 
suggests that patient acceptability and safety are key factors in provider endorsement of 
partner services26.
We found suboptimal levels of screening for sexual risk behaviors and for STDs among 
sexually active patients. This concurs with findings of low levels of STD screening among 
U.S. HIV patients27. Some providers may not be comfortable discussing sex with their 
patients28, but tools exist that may help providers enhance their skills in these areas. For 
example, “Ask, Screen, Intervene” and “Partnership for Health” are two interventions that 
provide courses, continuing education opportunities, and other materials to facilitate their 
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implementation by clinicians29, 30. Increasing service delivery in this area is essential 
because provider-delivered risk counseling can be effective in reducing sexual risk behaviors 
among HIV-infected persons2, 5, 6.
Nurse practitioners were independently more likely to provide adequate sex and substance 
use-related HIV transmission RR services to their patients. Although the role of nurse 
practitioners in delivery of HIV care has not been studied extensively, studies suggest that 
nurse practitioners provide similar quality HIV care as physicians31. In addition, several 
studies have indicated that nurse practitioners have similar primary care outcomes as 
physicians, but outperform physicians in measures of consultation time, patient-follow-up 
and patient satisfaction32. This analysis supports the key role of nurse practitioners in 
delivering comprehensive prevention services for HIV-infected persons and helps inform the 
debate regarding the future role of nurse practitioners in the delivery of HIV care33. As the 
number of HIV-infected persons needing care grows annually, nurse practitioners may play 
an essential role in delivering needed HIV transmission RR services.
Having more than 50% MSM patients was independently associated with lower delivery of 
sexual behavior-related RR. This finding concurs with patient-level data in which MSM 
report lower receipt of prevention counseling than other groups10. Enhanced efforts to 
improve this gap may be needed, as the risk of sexual transmission of HIV is substantially 
higher for MSM who engage in anal intercourse34. Although biomedical prevention 
strategies such as Treatment as Prevention and pre-exposure prophylaxis (PrEP) may hold 
great promise for populations disproportionately affected by HIV such as MSM, they will 
not supplant the need for continued delivery of RR services. An estimated 38% of HIV-
infected persons receiving medical care in 2011 had at least one unsuppressed viral load test 
result over the prior year16, which indicates a continued need for behavioral strategies to 
decrease risk of HIV transmission among sexually active persons and PWID in this group. 
Also, the success of PrEP as a prevention strategy may depend on expanding provider 
education and training programs so that all at-risk persons have access to PrEP. An analysis 
of 2013 MMP Provider Survey data found that only an estimated 26% of U.S. providers who 
care for HIV-infected and non-HIV-infected patients reported ever prescribing PrEP35.
That providers who also deliver primary care are more likely to deliver sexual behavior 
related RR is encouraging, and may indicate the complementary nature of HIV and primary 
care training. As the Institute of Medicine notes, as HIV-infected persons are living longer, 
there is an increased need for primary care skills among HIV care providers in order to meet 
their patients' health needs36. As the Affordable Care Act provides funding to community 
health centers to enhance HIV care and treatment services, a growing number of HIV-
infected persons may receive care from primary care providers and NPs, which may enhance 
delivery of RR services.
Having more than 50% PWID as patients was independently associated with delivery of 
substance use-related HIV transmission RR services, which may reflect the increased 
expertise and comfort with discussing substance use that comes with seeing larger numbers 
of patients for whom these services may be relevant. Also, providers who see many PWID 
may have more confidence in their ability to identify those in need of these services. 
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Meeting HIV specialist criteria was also associated with being more likely to deliver 
substance use related HIV transmission RR services. Although HIV specialist certification 
differs somewhat from credentialing through certification programs, given the recent debate 
about the value of maintaining certification programs and the difficulty in demonstrating 
their effect on quality of care37, this finding may warrant further exploration.
Our analysis is subject to several limitations. First, we did not assess delivery of every 
possible sexual behavior- and substance use-related RR service, for example delivery of 
more intensive behavioral RR interventions. However, we assessed a wide range of basic 
services that capture the minimum standard for provider-delivered RR. Second, our 
estimates of delivery of RR services are self-reported and may be subject to recall and social 
desirability bias. However, our findings concur with studies using direct observation 
methods, which have also found low rates of provision of these services11, 12. Third, we did 
not measure the quality or quantity of services delivered, so we cannot determine whether 
the delivery of services by providers was adequate to meet the patients' needs. For example, 
while Drainoni and colleagues28 found that almost all providers they surveyed discussed risk 
behaviors and transmission with their HIV-infected patients, most did not routinely probe for 
the reasons for risk behaviors and thus missed opportunities to provide effective counseling 
to reduce these behaviors. Fourth, we were unable to fully assess delivery of RR services by 
provider race/ethnicity because the numbers of black and Hispanic providers were low, 
leading to unstable estimates with wide confidence intervals. Future surveys could 
oversample non-white providers to address this limitation. Fifth, the MMP Provider Survey 
is designed to produce national estimates, but participating states may be able to generate 
locally representative estimates. Such analyses may be useful for evaluating the adequacy of 
local RR services and determining what changes are needed to improve the delivery of these 
services. Sixth, in some care settings provision of selected prevention services may be 
performed by non-clinical staff, and thus providers may not provide the service so as not to 
be duplicative. However, provider-delivered RR has been found to be especially effective in 
reducing risk behavior5, and provider awareness of patient risk behavior is essential for 
providing quality medical care, for example for determining need for STD screening2-4. 
Finally, while we chose to use a threshold of approximately 70% of services delivered for 
our composite measures, it is important to acknowledge that all services we examined are 
recommended by federal guidelines2. Despite this, we did not choose a threshold of 100% of 
services delivered because, as mentioned above, some services examined (e.g., condom 
provision, referral to partner services) require structural supports that are not entirely within 
the control of the provider. Also, because 100% delivery (or “all-or-nothing”) measures are 
sensitive to the number of items included in the composite measure, a 70% threshold has 
been suggested as an alternative measure of clinical quality20. Because all services examined 
are recommended by federal guidelines, we decided to give all services equal weight in the 
construction of our composite measures.
Despite biomedical advances in prevention strategies, supporting behavior change through 
RR services remains an essential component of an effective combination approach to HIV 
prevention. The recent publication of the updated federal recommendations for HIV 
prevention with persons with HIV2 provides an opportunity to refocus efforts on these 
important services. The HIV-infected population is growing as a result of a stable number of 
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annual new infections and increasingly effective treatments that reduce mortality. Further, as 
our national efforts to move individuals along the continuum of care result in increases in 
numbers of HIV-infected persons engaged in medical care, it is crucial that we ensure that 
providers of HIV care are aware of recommended prevention services and that they are 
provided with adequate training and support to assess and address HIV transmission risks 
among their patients. This analysis presents evidence that comprehensive transmission RR 
services are not delivered by a majority of providers to most of their patients, and identifies 
specific services that are in need of enhancement, such as RR at follow-up visits and referral 
to partner services. CDC has compiled a list of existing resources to support implementation 
of federal guidelines for HIV prevention (http://www.cdc.gov/hiv/prevention/programs/pwp/
resources.html) and will continue to monitor delivery of these services through provider 
surveys and other efforts to ensure that all persons with HIV are receiving needed services to 
prevent onward transmission and improve their health.
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Table 1
Provider and practice characteristics—2013 Medical Monitoring Project (MMP) Provider 
Survey, United States (n=1,234)
n wt. % 95% CI
Provider characteristics
Age (years)
 < 40 211 18 13-22
 40-49 326 24 21-27
 50-59 453 38 32-45
 60+ 204 20 15-25
Gender
 Male 620 57 50-63
 Female 585 43 37-50
Sexual orientation
 Heterosexual or straight 980 85 81-89
 Gay, lesbian, or bisexual 221 15 11-19
Race / ethnicity
 White, non-Hispanic 783 63 56-70
 Black, non-Hispanic 89 11^ 4-18
 Hispanic or Latino 158 11^ 4-18
 Other 179 16 11-21
Provider type
 ID board certified physician 564 45 37-52
 Non-ID board certified physician 380 35 28-42
 Nurse Practitioner 217 15 10-20
 Physician Assistant 63 5 3-8
Years caring for HIV patients
 0-5 years 231 18 13-22
 6-10 years 196 18 14-22
 11-20 years 428 36 32-40
 21+ years 365 29 25-33
HIV specialist
 No 369 42 36-49
 Yes 865 58 51-64
Provides primary care for HIV-infected patients
 No 128 17 12-22
 Yes 1094 83 78-88
Communicates in another language in addition to English to provide medical care
 No 694 61 54-69
 Yes 519 39 31-46
Number of patients
 0-20 patients 103 15 10-21
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n wt. % 95% CI
 21-50 patients 186 20 14-25
 51-200 patients 479 39 34-44
 200+ patients 437 26 20-32
Practice characteristics
Satisfaction with support services
 Less than satisfied or very satisfied 552 50 45-56
 Satisfied or very satisfied 667 50 44-55
Has sufficient time for new patients
 Sometimes or never 329 24 20-28
 Always or usually 877 76 72-80
Has sufficient time for established patients
 Sometimes or never 329 25 21-29
 Always or usually 894 75 71-79
Percentage of patients who are non-white
 0-50% 304 38 25-51
> 50% 907 62 49-75
Percentage of patients who are women
 0-50% 1153 94 90-97
> 50% 60 6 3-10
Percentage of patients who are men who have sex with men (MSM)
 0-50% 650 52 42-63
> 50% 563 48 37-58
Percentage of patients who are persons who inject drugs (PWID)
 0-50% 1178 97 93-100
> 50% 35 3^ 0-7
Practice utilizes an integrated team
 No 339 46 37-54
 Yes 874 54 46-62
CI, 95% confidence interval; ID, infectious diseases;
^
CV is greater than 0.30, estimate may be unreliable.
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Table 2
Prevalence of HIV transmission risk-reduction services—2013 MMP Provider Survey, 
United States
n wt. % 95% CI
Sexual behavior-related HIV risk-reduction services (n=1,214)*
Ask about any new sexual partners and number and gender of partners and assess ongoing risk behaviors every 6 months
 Most or all 669 54 47-61
 More than half 289 25 21-29
 About half 98 7 5-10
 Less than half 110 9 7-12
 Few or none 48 4 2-5
Ask about symptoms of STDs since the last visit in sexually active patients
 Most or all 627 54 49-59
 More than half 304 22 18-25
 About half 124 9 7-11
 Less than half 108 12 8-16
 Few or none 48 3^ 1-6
Provide safer sex counseling at each visit for patients with ongoing risky sexual behaviors or detectable viral load
 Most or all 734 59 54-65
 More than half 276 25 21-28
 About half 105 7 5-9
 Less than half 78 6 4-9
 Few or none 21 3^ 1-4
Offer condoms to sexually active patients
 Most or all 627 42 34-49
 More than half 179 11 8-13
 About half 50 3 2-4
 Less than half 71 6 4-9
 Few or none 279 38 30-47
Ask patients during their initial evaluation if all sexual partners since time of diagnosis have been notified of possible HIV exposure
 Most or all 704 62 56-69
 More than half 220 18 13-22
 About half 67 5 3-8
 Less than half 104 7 5-10
 Few or none 102 8 5-11
Ask patients during their follow-up visits if any new sexual partners have been notified of possible HIV exposure since their last visit
 Most or all 461 41 33-48
 More than half 251 19 15-22
 About half 128 11 7-14
 Less than half 180 15 12-19
 Few or none 190 15 11-19
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n wt. % 95% CI
Ask patients with newly diagnosed syphilis, gonorrhea, chlamydia, trichomoniasis (in women only) and HSV-2 if all sex partners have been 
informed of possible HIV exposure
 Most or all 828 69 63-76
 More than half 193 14 11-17
 About half 60 4 2-6
 Less than half 74 7^ 2-12
 Few or none 52 6 3-8
Encourage patients to disclose their HIV status to all sex partners since the time of their diagnosis
 Most or all 938 81 77-84
 More than half 150 11 8-13
 About half 49 3 2-5
 Less than half 43 3 2-4
 Few or none 29 3 1-4
Refer patients to health department to discuss sex partners who have not been informed of their exposure and to arrange for their notification 
and referral for HIV testing
 Most or all 558 53 45-60
 More than half 193 14 9-19
 About half 78 6 4-9
 Less than half 135 11 7-15
 Few or none 235 16 12-19
Adequate sexual behavior-related risk-reduction services
 Yes 432 37 29-45
 No 750 63 55-71
Substance use-related HIV transmission risk-reduction services (n=1,207)§
Assess use of alcohol, recreational drugs, illicit drugs, and elicit injected drugs every 6 months
 Most or all 788 64 57-71
 More than half 249 23 17-29
 About half 82 7 5-9
 Less than half 55 4 2-6
 Few or none 33 2^ 1-3
Ask injection drug users during their initial evaluation if all injection partners have been informed of possible HIV exposure
 Most or all 560 58 49-66
 More than half 160 17 10-25
 About half 71 7 5-9
 Less than half 88 7 4-11
 Few or none 135 11 8-14
Ask injection drug users at follow-up visits if any new injection partners have been informed of possible HIV exposure since their last visit
 Most or all 404 41 32-50
 More than half 221 21 17-25
 About half 80 9 6-12
 Less than half 130 14 8-20
 Few or none 178 15 12-19
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n wt. % 95% CI
Encourage patients to disclose their HIV status to all injection partners since the time of their HIV diagnosis
 Most or all 598 61 53-68
 More than half 172 17 13-21
 About half 57 5 2-8
 Less than half 82 8^ 3-14
 Few or none 124 9 7-12
Refer patients to health department to discuss drug injection partners who have not been informed of their exposure and to arrange for their 
notification and referral for HIV testing.
 Most or all 403 45 39-51
 More than half 165 16 12-20
 About half 71 6 4-8
 Less than half 119 14 9-19
 Few or none 253 20 15-24
For patients who abuse alcohol or drugs, make referrals for appropriate specialty services
 Most or all 775 57 50-63
 More than half 250 23 19-28
 About half 78 10 5-14
 Less than half 49 5 2-8
 Few or none 47 5 2-8
Inform patients who share drug injection equipment about sources of sterile syringes (e.g., pharmacies, syringe programs, legal prescription in 
some states)
 Most or all 480 43 37-48
 More than half 176 18 13-24
 About half 67 6 5-8
 Less than half 89 9 6-12
 Few or none 199 24 18-30
Adequate substance use-related risk-reduction services
 Yes 403 43 35-51
 No 552 57 49-65
CI, 95% confidence interval;
*
Adequate sexual behavior-related risk-reduction was defined as performing at least 7 of 9 sexual behavior-related risk-reduction activities for most 
or all patients who met certain characteristics (6 of 8 services for providers who did not see patients for initial visits).
§
Adequate substance use-related risk-reduction was defined as performing 5 of 7 substance use-related risk-reduction activities for most or all 
patients who met certain characteristics (4 of 6 services for providers who did not see patients for initial visits; providers with no intravenous drug 
using patients were excluded).
^
CV is greater than 0.30, estimate may be unreliable.
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